[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559958":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":22,"responsibleParty":81,"collaborators":7,"id":83,"slug":84,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":7,"eligibilityCriteria":89,"healthyVolunteers":85,"sex":90,"minAge":91,"maxAge":7,"enrollmentInfo":92,"targetDuration":95,"studyType":96,"phases":7,"briefSummary":97,"conditions":98,"keywords":7,"overallStatus":42,"whyStopped":7,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Zoll Medical Corporation","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","WCD","An FDA-approved, CE marked WCD will be prescribed for up to 3 months of use after hospital discharge, with the option for longer use under physician discretion",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Lars Weber, M.Sc.","CONTACT","015161140498","lweber@zoll.com",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},"Horst-O. Esser","hesser@zoll.com",[23,40,54,68],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Kerckhoff Klinik","NOT_YET_RECRUITING","Bad Nauheim","Hesse","61231","Germany","DE",{"type":32,"coordinates":33},"Point",[34,35],8.73859,50.36463,{"lat":35,"lon":34},[38],{"name":39,"role":16,"phone":7,"phoneExt":7,"email":7},"Heiko Burger (Dr.), MD",{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":29,"countryCode":30,"cosmosGeoPoint":46,"geoPoint":50,"contacts":51},"Medizinische Hochschule Hannover","RECRUITING","Hanover","Lower Saxony","30625",{"type":32,"coordinates":47},[48,49],9.73322,52.37052,{"lat":49,"lon":48},[52],{"name":53,"role":16,"phone":7,"phoneExt":7,"email":7},"Christian Kühn (Prof. Dr.), MD",{"facility":55,"status":42,"city":56,"state":7,"zip":57,"country":29,"countryCode":30,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Sana-Herzzentrum Cottbus GmbH","Cottbus","03048",{"type":32,"coordinates":59},[60,61],14.32888,51.75769,{"lat":61,"lon":60},[64,66],{"name":65,"role":16,"phone":7,"phoneExt":7,"email":7},"Tomasz Stankowski, MD",{"name":65,"role":67,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"facility":69,"status":42,"city":70,"state":7,"zip":71,"country":29,"countryCode":30,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Universitätsklinikum Halle (Saale)","Halle","06120",{"type":32,"coordinates":73},[74,75],11.97947,51.48158,{"lat":75,"lon":74},[78,80],{"name":79,"role":16,"phone":7,"phoneExt":7,"email":7},"Songül Secer, MD",{"name":79,"role":67,"phone":7,"phoneExt":7,"email":7},{"type":82,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100559958","prospective-wcd-post-cabg-registry-cabg-registry-100559958",false,"NCT06570902","Prospective WCD Post CABG Registry (CABG Registry)","Prospective WCD Post CABG Registry","Inclusion Criteria\n\n* Patient underwent first-time CABG surgery \\\u003C10 days before enrollment.\n* Patient is prescribed WCD for a primary reason of HF with reduced EF \\\u003C 35% measured after surgery but before hospital discharge.\n* Patient is ≥18 years old\n\nExclusion Criteria:\n\n* Patients having combination CABG surgery with heart valve repair.\n* Patients with prior CABG.\n* Patients who have an active unipolar pacemaker.\n* Patients with a physical or mental condition that could impair their ability to properly interact with the WCD.\n\nPatients currently participating in an interventional clinical study. Patients with any skin condition that would prevent wearing the device. Patients with an advanced directive prohibiting resuscitation.","ALL","18 Years",{"count":93,"type":94},910,"ESTIMATED","12 Months","OBSERVATIONAL","The primary objective is to observe the rate of recovery of ventricular function (EF\\>35%) after first-time coronary artery bypass graft surgery in patients who were prescribed the wearable cardioverter defibrillator (WCD) post-surgery prior to being discharged after hospitalization as part of standard clinical care.",[99,100,101,102],"Cardiomyopathy Ischemic","Cardiomyopathies","Cardiovascular Diseases","Heart Disease, Ischemic","2024-10-31",{"date":105,"type":106},"2024-11-04","ACTUAL",{"date":108,"type":106},"2024-09-23",{"date":110,"type":94},"2030-05",{"name":5,"class":6},4]